Description

Product Description:

This compound is a synthetic triple receptor agonist designed to interact with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is part of a class of multi-functional peptides studied for their role in integrated metabolic signaling and endocrine pathway modulation.

In research environments, triple agonists are utilized to examine multi-pathway receptor activation, enabling the study of complex biological interactions involving energy regulation, hormonal signaling, and receptor dynamics.

Due to their ability to engage multiple receptor systems simultaneously, these compounds are commonly applied in in vitro and experimental models focused on metabolic pathway integration and peptide-receptor signaling networks.

Key Features:

Compound Type: Triple receptor agonist (GLP-1 / GIP / Glucagon)
Molecular Formula: Proprietary peptide structure
CAS Number: Not disclosed / research reference compound
Structure: Multi-receptor agonist peptide analog
Physical Form: Lyophilized powder
Compound Class: Synthetic peptide / multi-incretin agonist
Purity: ≥98% (HPLC)
Storage Conditions: Store at 36–46°F (2–8°C) in a dry, light-protected environment.

Research References:

• Jastreboff, A. M. et al. (2023). Triple–hormone receptor agonists in metabolic research. New England Journal of Medicine.
• Coskun, T. et al. (2022). Multi-receptor peptide agonists and metabolic pathway integration. Cell Metabolism.
• Drucker, D. J. (2018). Advances in incretin-based therapies and receptor signaling. Cell Metabolism.

(References provided for informational and research context only.)

Important Notice:

This product is intended for research use only. It is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to qualified professionals in controlled laboratory environments.